MAR vs MELI: Which Is the Better Buy?

Side-by-side comparison of Marriott International, Inc. and MercadoLibre, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-20.
Marriott International, Inc. Β· Consumer Cyclical
$366.24
-3.4% upside to fair value
Med Conviction Grade C
VS
MercadoLibre, Inc. Β· Consumer Cyclical
$1,635.15
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
MELI has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MAR MELI
Current Price $366.24 $1,635.15
Fair Value Estimate $353.64 $2,370.97
Upside to Fair Value -3.4% +45.0%
Market Cap $96.6B $82.9B
Forward P/E β€” 43.2x
EV / EBITDA 23.8x 27.0x
Price / Sales 3.7x 2.6x
Price / FCF 31.6x 7.7x
Revenue Growth YoY +6.2% +49.0%
Gross Margin 21.4% 43.9%
Operating Margin 16.0% 9.6%
Return on Equity -74.1% 29.6%
Dividend Yield 0.75% 0%
FCF Yield 3.17% 12.92%
Analyst Consensus Hold Strong Buy
Investment Thesis
MAR β€” Marriott International, Inc.
Marriott International is a global asset-light hotel franchisor, manager and licensor whose high-quality brands, nearly 283 million Bonvoy members, more than 9,900 properties across 146 countries and record 4,107-property development pipeline create meaningful network, distribution and brand advantages. Q1 2026 demonstrated resilient underlying fee economics: adjusted revenue excluding cost-reimb…
MELI β€” MercadoLibre, Inc.
MercadoLibre is a leading Latin American e-commerce and fintech platform with a durable competitive moat driven by its integrated logistics and financial services stack. The company commands approximately 30 to 35 percent market share in e-commerce and over 30 percent in online payments in key markets like Brazil. It is founder-influenced with a long-tenured management team and reinvests heavily …
Accumulation Zones
Metric MAR MELI
Zone Low $265.23 $1,778.23
Zone High $300.59 $2,015.32
In Buy Zone? No Yes
← MAR Research    MELI Research β†’    All Research